FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095413 [Registered on: 25/09/2025] Trial Registered Prospectively
Last Modified On: 25/09/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmetics]  
Study Design  Single Arm Study 
Public Title of Study   A study to evaluate the efficacy and safety of the test product on the tanned skin. 
Scientific Title of Study   A clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female participants. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
C3B06105; Version: 01, Dated 01 Sep 25  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhagirath Patel 
Designation  Principal Investigator 
Affiliation  Cliantha Research 
Address  Consumer Research Department, Corporate House 17, Sigma 1 Corporate House, BH. Rajpath Club, Off Sindhubhavan Rd, Nr. Mann Party Plot Crossroad, Bodakdev, Ahmedabad-380054. Phone# 07966135601

Ahmadabad
GUJARAT
380054
India 
Phone  9825618138  
Fax    
Email  bpatel3@cliantha.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Divya Mori 
Designation  Medical Monitor 
Affiliation  Cliantha Research 
Address  Consumer Research Department, Corporate House 17, Sigma 1 Corporate House, BH. Rajpath Club, Off Sindhubhavan Rd, Nr. Mann Party Plot Crossroad, Bodakdev, Ahmedabad-380054. Phone# 07966135601

Ahmadabad
GUJARAT
380054
India 
Phone  9773262487  
Fax    
Email  damori@cliantha.com  
 
Details of Contact Person
Public Query
 
Name  Dr Parth Joshi 
Designation  Overall Study Coordinator 
Affiliation  Cliantha Research  
Address  Consumer Research Department, Corporate House 17, Sigma 1 Corporate House, BH. Rajpath Club, Off Sindhubhavan Rd, Nr. Mann Party Plot Crossroad, Bodakdev, Ahmedabad-380054. Phone# 07966135601

Ahmadabad
GUJARAT
380054
India 
Phone  8000085049  
Fax    
Email  pjoshi@cliantha.com  
 
Source of Monetary or Material Support  
Cliantha Research, Corporate House 17, Sigma 1 Corporate House, BH. Rajpath Club, Off Sindhubhavan Road, Nr. Mann Party Plot Cross Road, Bodakdev, Ahmedabad-380054, Gujarat, India. 
Zydus Wellness Products Limited, Plot No 115/5 TP Scheme No 51, Beside Bliss Apartment, Opp Viola Apartment, Ambli Bopal Road, Ahmedabad 380015  
 
Primary Sponsor  
Name  Zydus Wellness Products Limited 
Address  Plot No 115/5 TP Scheme No 51 Beside Bliss Apartment, Opp Viola Apartment, Ambli Bopal Road, Ahmedabad 380015. 
Type of Sponsor  Other [Health and Hygiene] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhagirath Patel  Cliantha Research  Consumer Research Department, Corporate House 17, Sigma 1 Corporate House, BH. Rajpath Club, Off Sindhubhavan Road, Nr. Mann Party Plot Cross Road, Bodakdev, Ahmedabad-380054.
Ahmadabad
GUJARAT 
9825618138

bpatel3@cliantha.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
OM Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy participants with visible tanned skin. 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CL-TRFW-25  Approx. 1 gm of product will be applied twice a week during the entire study duration. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1) Non-pregnant /non-lactating females.
2) Participants with fitzpatrick skin type IV and V.
3) Participants with visible skin tan on face, at least 2 shade darker than a Sun protected upper volar arm.
4) Participants with visible blackheads on the face.
5) Participants with at least 2 blemishes.
6) Participants who are willing to voluntarily participate in the study and provide signed informed consent.
 
 
ExclusionCriteria 
Details  1) Participants with dark facial skin as determined by dermatologist.
2) Participants having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments.
3) Participants using any other facewash during the study period.
4) Participants using other marketed skin lightening products during the study period or in the past 6 weeks.
5) Participants who are receiving topical or systemic treatments for pigmentation within the last 30 days.
6) Participant undergoing treatment for Seborrhoea, Acne, Dermatitis, Melasma, Lentigines, skin Lightening/ any other cosmetic/ dermatologic skin condition on face. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the efficacy of test product on tanned skin, based on instrumental evaluations.  Day 01 (Before and after product usage) , Day 03, Day 07, Day 14 and Day 21. 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the efficacy of test product on tanned skin, based on clinical, instrumental and subjective evaluations.  Day 01 (Before and after product usage) , Day 03, Day 07, Day 14 and Day 21. 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is an open label, non-randomized, single-center, single-arm clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female participants.

The potential participants will be screened as per the inclusion and exclusion criteria only after obtaining written informed consent from the participants.

All eligible participants will undergo clinical evaluation by a Dermatologist, instrument evaluation and subjective evaluation. Safety will be assessed throughout the study by monitoring adverse events.
 
Close